skip to main content

Listen

Read

Watch

Schedules

Programs

Events

Give

Account

Donation Heart Ribbon

Why We’re Losing The War On Cancer And How We Can Win It

Evening Edition

San Diego has a thriving medical research community and much of that research is directed toward finding new treatments for various forms of cancer.

However, while progress has been made to increase survival rates for some forms of cancer, many cancers remain just as deadly as they were 40 years ago. It was back then that America declared "war on cancer" sinking hundreds of billions of dollars into research.

Aired 10/2/13 on KPBS Midday Edition.

GUEST:

Clifton Leaf, author, The Truth in Small Doses: Why We're Losing the War on Cancer -- and How to Win It

Transcript

CliftonLeaf.com

"The Truth in Small Doses: Why We're Losing the War on Cancer—and How to Win It" is a book by Clifton Leaf.

The rate at which cancer treatment has advanced compared with the time, money and effort being spent on cancer research, just doesn't add up for journalist and former cancer patient Clifton Leaf.

He is the first featured speaker in the first installment of UC San Diego's 2013-14 Exploring Ethics series, titled “Overthrowing the Emperor of All Maladies: Moving Forward Against Cancer.”

Leaf will examine the study and treatment of cancer, one of the world’s most vexing medical challenges dating back to antiquity. He is author of the recently acclaimed book, "The Truth in Small Doses: Why We’re Losing the War on Cancer -- And How to Win It." The intriguing topic of his presentation, “Lessons from a One-Eyed Surgeon,” refers to a famed Irish surgeon and medical author named Denis Burkitt, whose inspiring story Leaf recounts in his book.

Leaf is also in San Diego for "The Atlantic Meets the Pacific," a joint conference hosted by The Atlantic and UC San Diego.

Please stay on topic and be as concise as possible. Leaving a comment means you agree to our Community Discussion Rules. We like civilized discourse. We don't like spam, lying, profanity, harassment or personal attacks.

comments powered by Disqus